
BioXcel Therapeutics Investor Relations Material
Latest events

Q3 2024
BioXcel Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from BioXcel Therapeutics Inc
Access all reports
BioXcel Therapeutics, Inc. is a biopharmaceutical company focused on utilizing artificial intelligence to discover and develop new therapies in neuroscience and immuno-oncology. The company leverages its proprietary AI platform to identify and advance drug candidates for the treatment of complex conditions, including psychiatric disorders and cancers. BioXcel Therapeutics is engaged in both clinical and preclinical development. The company is headquartered in New Haven, United States, and its shares are listed on the NASDAQ.
Latest articles
)
James Quincey: Coca-Cola Chairman and CEO
James Quincey has dedicated nearly three decades to The Coca-Cola Company, rising through the ranks to become CEO and Chairman of the company.
11 Mar 2025
)
PepsiCo: From Pepsi and Gatorade to Doritos and Lay's
PepsiCo has grown from a soda company into a global leader in food and beverages, with a portfolio of over 200 brands, including Pepsi, Lay's, and Gatorade.
11 Mar 2025
)
Bob Iger: Disney's Visionary CEO
Bob Iger is a legend in the entertainment industry, known for his visionary leadership and as one of the most influential CEOs in Disney's history.
10 Mar 2025
Ticker symbol
BTAI
Country
🇺🇸 United States